Precision BioSciences
DTIL
DTIL
47 hedge funds and large institutions have $30.8M invested in Precision BioSciences in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
28% less capital invested
Capital invested by funds: $42.8M → $30.8M (-$12.1M)
29% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 14
Holders
47
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$586K | |
| 2 | +$329K | |
| 3 | +$257K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$166K |
| 5 |
Goldman Sachs
New York
|
+$153K |
Top Sellers
| 1 | -$716K | |
| 2 | -$527K | |
| 3 | -$161K | |
| 4 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
-$154K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$137K |